Filtered By:
Source: Cancer Chemotherapy and Pharmacology
Drug: Alimta
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
ConclusionsThe use of peripheral blood samples for expression quantification of interest genes is an affordable method with promising results in the evaluation of response to pemetrexed treatment. Therefore, expression levels ofREV3L andTYMS genes might be used as predictive biomarkers in advanced NSCLC patients.
Source: Cancer Chemotherapy and Pharmacology - December 11, 2019 Category: Cancer & Oncology Source Type: research
